NutriSystem (NTRI) Rating Increased to Neutral at DA Davidson

Share on StockTwits

NutriSystem (NASDAQ:NTRI) was upgraded by equities research analysts at DA Davidson from an “underperform” rating to a “neutral” rating in a report released on Thursday, The Fly reports.

Several other equities research analysts have also weighed in on the stock. ValuEngine raised shares of NutriSystem from a “strong sell” rating to a “sell” rating in a report on Friday, October 12th. Zacks Investment Research lowered shares of NutriSystem from a “buy” rating to a “hold” rating in a report on Wednesday, August 1st. Barrington Research reaffirmed a “hold” rating on shares of NutriSystem in a report on Wednesday, August 1st. Finally, BidaskClub raised shares of NutriSystem from a “sell” rating to a “hold” rating in a report on Saturday, October 13th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $44.50.

Shares of NTRI stock opened at $35.56 on Thursday. NutriSystem has a 52-week low of $26.06 and a 52-week high of $55.10. The firm has a market capitalization of $982.25 million, a PE ratio of 18.14, a price-to-earnings-growth ratio of 1.62 and a beta of 1.27.

NutriSystem (NASDAQ:NTRI) last announced its quarterly earnings data on Tuesday, October 30th. The company reported $0.54 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.54. NutriSystem had a net margin of 8.06% and a return on equity of 44.33%. The company had revenue of $159.30 million during the quarter, compared to analysts’ expectations of $164.18 million. During the same quarter in the prior year, the company posted $0.49 EPS. The business’s revenue was up .8% on a year-over-year basis. Sell-side analysts forecast that NutriSystem will post 2.06 earnings per share for the current year.

NutriSystem announced that its Board of Directors has approved a share repurchase program on Tuesday, October 30th that authorizes the company to buyback $75.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 7.7% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s leadership believes its shares are undervalued.

A number of large investors have recently modified their holdings of the business. US Bancorp DE grew its holdings in NutriSystem by 64.7% during the 2nd quarter. US Bancorp DE now owns 3,726 shares of the company’s stock worth $143,000 after acquiring an additional 1,464 shares during the last quarter. Principal Financial Group Inc. boosted its stake in shares of NutriSystem by 0.8% in the 1st quarter. Principal Financial Group Inc. now owns 250,443 shares of the company’s stock valued at $6,749,000 after purchasing an additional 2,095 shares during the last quarter. Legal & General Group Plc boosted its stake in shares of NutriSystem by 3.9% in the 2nd quarter. Legal & General Group Plc now owns 63,544 shares of the company’s stock valued at $2,434,000 after purchasing an additional 2,378 shares during the last quarter. Lapides Asset Management LLC boosted its stake in shares of NutriSystem by 2.2% in the 2nd quarter. Lapides Asset Management LLC now owns 120,500 shares of the company’s stock valued at $4,639,000 after purchasing an additional 2,600 shares during the last quarter. Finally, First Mercantile Trust Co. bought a new position in shares of NutriSystem in the 2nd quarter valued at about $119,000.

NutriSystem Company Profile

Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ‘D' kit that offers individuals with or at risk of type 2 diabetes.

Featured Story: Asset Allocation, Balancing Your Investments

The Fly

Analyst Recommendations for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply